C. Orvig

T. Storr, R. Chammas, C. Orvig, 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc).

U. Häfeli, Ripen Misri, C. Orvig, 2009, Dalton transactions.

99m-Technetium carbohydrate conjugates as potential agents in molecular imaging.

C. Orvig, M. Bowen, 2008, Chemical communications.

Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular 89Zr-THPN-Conjugates.

F. Bénard, U. Häfeli, P. Schaffer, 2019, Inorganic chemistry.

What a Difference a Carbon Makes: H4octapa vs H4C3octapa, Ligands for In-111 and Lu-177 Radiochemistry

Jason S. Lewis, B. Zeglis, C. Orvig, 2014, Inorganic chemistry.

IN VIVO ELECTRON SPIN-ECHO ENVELOPE MODULATION (ESEEM) SPECTROSCOPY : FIRST OBSERVATION OF VANADYL COORDINATION TO PHOSPHATE IN BONE

J. McNeill, S. Dikanov, C. Orvig, 1999 .

Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent Dyes.

P. Mcgeer, M. O. Wolf, Xiaolei Shi, 2017, Angewandte Chemie.

Lipophilic coordination compounds: aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones

C. Orvig, S. Rettig, Zaihui Zhang, 1991 .

Tightening the Hydrophobic Belt: Effects of Backbone and Donor Group Variation on Podand Ligand Complexes of the Lanthanides

P. Caravan, C. Orvig, S. Rettig, 1998 .

Vanadium compounds as possible insulin modifiers

C. Orvig, K. Thompson, M. Cam, 1999 .

Lanthanide complexes of potentially heptadentate ligands including the structure of [tris(3-aza-4-methylhept-4-ene-6-on-1-yl)amine]tris(nitrato)gadolinium(III)

C. Orvig, S. Rettig, Alexis Smith, 1988 .

Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p-xylenyl-linked quinolone ligands.

M. Abrams, C. Orvig, E. Polishchuk, 2016, Journal of inorganic biochemistry.

Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin.

C. Orvig, G. Jamieson, J. Fox, 2015, Dalton transactions.

Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates.

V. Yardley, Peter J. Smith, C. Orvig, 2006, Inorganic chemistry.

An Iron-Based Molecular Redox Switch as a Model for Iron Release from Enterobactin via the Salicylate Binding Mode.

Philipp Gütlich, Thomas R. Ward, Chris Orvig, 1999, Inorganic chemistry.

Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats.

D. Lyster, M. Battell, J. McNeill, 1998, Journal of applied physiology.

La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)3 and La(XT), and evaluation as treatments for bone resorption disorders.

E. Wasan, K. Wasan, A. Panahifar, 2017, Metallomics : integrated biometal science.

N-Aryl-substituted 3-(β-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy

T. Storr, C. Rodríguez-Rodríguez, B. Page, 2011 .

Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

H. Schugar, T. Storr, P. Lockman, 2007, Angewandte Chemie.

Ion exchange in hydroxyapatite with lanthanides.

C. Haynes, A. Creagh, C. Orvig, 2015, Inorganic chemistry.

Polydentate ligand chemistry of Group 13 metals: effects of the size and donor selectivity of metal ions on the structures and properties of aluminum, gallium, and indium complexes with potentially heptadentate (N4O3) amine phenol ligands

Shuang Liu, C. Orvig, S. Rettig, 1992 .

Editorial: lanthanide compounds for therapeutic and diagnostic applications.

C. Orvig, K. Thompson, 2006, Chemical Society reviews.

Aluminum and gallium compounds of 3-hydroxy-4-pyridinones: synthesis, characterization, and crystallography of biologically active complexes with unusual hydrogen bonding

C. Orvig, S. Rettig, W. Nelson, 1988 .

In vitro studies of lanthanide complexes for the treatment of osteoporosis.

K. Wasan, C. Orvig, J. Cawthray, 2013, Dalton transactions.

Evidence for energy-dependent transport of aluminum out of brain extracellular fluid.

R. Yokel, C. Orvig, D. D. Allen, 1995, Toxicology.

Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy.

R. Yokel, C. Orvig, D. D. Allen, 1994, Toxicology.

Potential 99mTc radiopharmaceuticals for renal imaging: tris(N-substituted-3-hydroxy-2-methyl-4-pyridinonato)technetium(IV) cations.

D. Lyster, Z. Zhang, C. Orvig, 1993, Nuclear Medicine and Biology.

Potential 67Ga radiopharmaceuticals for myocardial imaging: tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes.

D. Lyster, Z. Zhang, C. Orvig, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Aluminum and Gallium Compounds of 3-Hydroxy-4-pyridinones: Synthesis, Characterization, and Crystallography of Biologically Active Complexes with Unusual Hydrogen Bonding.

C. Orvig, S. Rettig, W. Nelson, 1988 .

Solution chemistry of gallium and indium 3-hydroxy-4-pyridinone complexes in vitro and in vivo

D. Lyster, C. Orvig, W. Nelson, 1990 .

The complexation of aluminum with N-substituted 3-hydroxy-4-pyridinones

C. Orvig, W. Nelson, A. Nordin, 1989 .

Comparison of ligands of differing denticity and basicity for the in vivo chelation of aluminium and gallium

C. Orvig, David J. Clevette, 1990 .

Aluminum and gallium complexes of 1-ethyl-3-hydroxy-2-methyl-4-pyridinone: a new exoclathrate matrix

C. Orvig, S. Rettig, W. Nelson, 1989 .

Metal chelation with natural products: isomaltol complexes of aluminum, gallium, and indium

C. Orvig, S. Rettig, Tammy G. Lutz, 1989 .

1-n-Propyl- and 1-n-butyl-3-hydroxy-2-methyl-4-pyridinone complexes of group 13 (IIIA) metal ions

C. Orvig, S. Rettig, J. Trotter, 1991 .

Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease.

C. Rodríguez-Rodríguez, M. Telpoukhovskaia, C. Orvig, 2013, Molecular bioSystems.

55Cobalt complexes with pendant carbohydrates as potential PET imaging agents.

T. Ruth, C. Orvig, M. Adam, 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

H2CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [nat/67/68Ga]Ga3.

U. Häfeli, Jinhe Pan, K. Saatchi, 2020, Inorganic chemistry.

New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake.

Eszter Boros, Chris Orvig, E. Boros, 2011, Nuclear medicine and biology.

Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration.

Brian O Patrick, Eszter Boros, Chris Orvig, 2010, Journal of the American Chemical Society.

Mononuclear to Tetranuclear Structural Transformation in Vanadyl Complexes of 3-Hydroxypyridine-2-carboxylic Acid (H2hpic)

H. Sakurai, Masako Kato, M. Mikuriya, 2002 .

Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron

M. Battell, J. McNeill, C. Orvig, 2002, Biological Trace Element Research.

Bulky ortho 3-methoxy groups on N4O3 amine phenol ligands producing six-coordinate bis(ligand)lanthanide complex cations [Ln(H3L)2]3+ (Ln = Pr, Gd; H3L = tris(((2-hydroxy-3-methoxybenzyl)amino)ethyl)amine)

Shuang Liu, C. Orvig, S. Rettig, 1993 .

Intestinal absorption of trace amounts of aluminium in rats studied with 26aluminium and accelerator mass spectrometry.

V. Sossi, P. Kubik, M. Schulzer, 1997, Clinical science.

Design and Synthesis of Multidentate 2‐(2′‐Hydroxyphenyl)‐2‐ thiazolines for Biomedical Application.

V. Karunaratne, C. Orvig, H. Hoveyda, 1992 .

Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III).

C. Orvig, B. Patrick, R. Stick, 2005, Bioconjugate chemistry.

In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors.

C. Rodríguez-Rodríguez, M. Telpoukhovskaia, C. Orvig, 2016, Bioorganic & medicinal chemistry letters.

Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones.

C. Rodríguez-Rodríguez, B. Page, M. Telpoukhovskaia, 2014, Journal of inorganic biochemistry.

Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone.

J. McNeill, C. Orvig, K. Thompson, 2004, Journal of inorganic biochemistry.

99m‐Technetium Carbohydrate Conjugates as Potential Agents in Molecular Imaging

C. Orvig, M. Bowen, 2009 .

Chemical and in vivo studies of the anion oxo[N,N'-ethylenebis(2-mercaptoacetimido)]Technetate(V).

S. Carr, K. Biemann, C. Costello, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A new class of oxotechnetium(5+) chelate complexes containing a TcON2S2 core

Alun G. Jones, C. Orvig, A. Davison, 1981 .

Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent.

Zhenfeng Chen, C. Orvig, Xing Lu, 2020, Journal of medicinal chemistry.

Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

C. Orvig, L. Scott, 2010 .

H4HBEDpa: Octadentate Chelate after A. E. Martell.

N. Choudhary, C. Orvig, B. Patrick, 2021, Inorganic chemistry.

Functionally Versatile and Highly Stable Chelator for 111In and 177Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting.

F. Bénard, Hsiou‐Ting Kuo, P. Schaffer, 2019, Bioconjugate chemistry.

Glucosamine conjugates of tricarbonylcyclopentadienyl rhenium(I) and technetium(I) cores.

C. Orvig, B. Patrick, M. Adam, 2006, Inorganic chemistry.

Radiopharmaceuticals for diagnosis in nuclear medicine: a short review

C. Orvig, A. Massabni, Filipe Boccato Payolla, 2019, Eclética Química Journal.

Coordination chemistry of [Y(pypa)]- and comparison immuno-PET imaging of [44Sc]Sc- and [86Y]Y-pypa-phenyl-TRC105.

W. Cai, J. Engle, T. Barnhart, 2020, Dalton transactions.

Announcment: 31st International Conference on Coordination Chemistry

L. Lindoy, C. Orvig, M. D. Fryzuk, 1995, Metal-based drugs.

Group 13 and lanthanide complexes with mixed O,S anionic ligands derived from maltol.

C. Orvig, B. Patrick, Vishakha Monga, 2005, Inorganic chemistry.

Rhenium(V) and technetium(V) complexes of bidentate (O,O) monobasic 3-oxy-4-pyronato and -4-pyridinonato ligands. X-ray structures of cis-bromobis(3-methyl-2-oxy-4-pyronato)oxorhenium(V), tetra-n-butylammonium tribromo(3-methyl-2-oxy-4-pyronato)oxorhenate(V), and tetra-n-butylammonium trichloro(3-me

C. Orvig, S. Rettig, H. Luo, 1993 .

Exoclathrate Al(C7H8NO2)3.cntdot.12H2O. A facial geometry imposed by extensive hydrogen bonding with the ice I structure

C. Orvig, S. Rettig, W. Nelson, 1987 .

Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry.

P. Comba, N. Choudhary, C. Orvig, 2019, Inorganic chemistry.

Dipicolinate Complexes of Gallium(III) and Lanthanum(III).

C. Orvig, B. Patrick, Lisa Murphy, 2016, Inorganic chemistry.

High denticity oxinate-linear-backbone chelating ligand for diagnostic radiometal ions [111In]In3+ and [89Zr]Zr4.

H. Stephan, C. Orvig, V. Radchenko, 2021, Dalton transactions.

H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.

Jason S. Lewis, B. Zeglis, C. Orvig, 2013, Journal of the American Chemical Society.

Multi-Target Metal-Based Anticancer Agents.

Zhenfeng Chen, C. Orvig, H. Liang, 2017, Current Topics in Medicinal Chemistry.

Carbohydrate conjugates for molecular imaging and radiotherapy: 99mTc(I) and 186Re(I) tricarbonyl complexes of N-(2'-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose.

T. Storr, C. Orvig, M. Adam, 2004, Bioconjugate chemistry.

tBu4octapa-alkyl-NHS for metalloradiopeptide preparation.

F. Bénard, Hsiou‐Ting Kuo, P. Schaffer, 2020, Dalton transactions.

One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co.

U. Häfeli, E. Boros, C. Orvig, 2011, Dalton transactions.

Coaggregation of paramagnetic d- and f-block metal ions with a podand-framework amine phenol ligand.

D. Hibbs, R. Thompson, M. Pink, 2000, Inorganic chemistry.

Gallium and Indium Complexes of Hexadentate Ligands Containing Pendant Pyridyl and Phenolate Groups

Shuang Liu, C. Orvig, S. Rettig, 1995 .

Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models.

Zhenfeng Chen, C. Orvig, Xing Lu, 2019, European journal of medicinal chemistry.

Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with 119Sb.

J. Engle, T. Barnhart, P. Ellison, 2023, Nuclear medicine and biology.

Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents.

Zhenfeng Chen, C. Orvig, Xing Lu, 2020, Current molecular medicine.

Toward 68Ga and 64Cu Positron Emission Tomography Probes: Is H2dedpa-N,N′-pram the Missing Link for dedpa Conjugation?

P. Schaffer, C. Orvig, B. Patrick, 2023, Inorganic chemistry.

Design, synthesis, and imaging of small amphiphilic rhenium and (99m)technetium tricarbonyl complexes.

U. Häfeli, E. Boros, C. Orvig, 2009, Bioconjugate chemistry.

Structural studies of organoboron compounds. XXVII. (3-Hydroxy-2-methyl-4-pyridinonato)diphenylboron and (3-hydroxy-1,2-dimethyl-4-pyridinonato)diphenylboron

C. Orvig, S. Rettig, W. Nelson, 1988 .

Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re).

C. Orvig, M. Adam, S. Bayly, 2006, Bioconjugate chemistry.

Radioactive Main Group and Rare Earth Metals for Imaging and Therapy.

C. Orvig, Thomas I Kostelnik, 2018, Chemical reviews.

Rearmed Bifunctional Chelating Ligand for 225Ac/155Tb Precision-Guided Theranostic Radiopharmaceuticals─H4noneunpaX.

H. Yang, P. Schaffer, C. Orvig, 2023, Journal of medicinal chemistry.

H4octapa: an acyclic chelator for 111In radiopharmaceuticals.

E. Boros, C. Orvig, M. Adam, 2012, Journal of the American Chemical Society.

In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease.

H. Schugar, C. Orvig, K. Thompson, 2010, Dalton transactions.

Metallodrugs in medicinal inorganic chemistry.

C. Orvig, Katja Dralle Mjos, 2014, Chemical reviews.

Trastuzumab-conjugated oxine-based ligand for [89Zr]Zr4+ immunoPET.

F. Bénard, H. Yang, C. Orvig, 2022, Journal of inorganic biochemistry.

[ReO(N2O2)X] complexes: "4 + 1"?

C. Orvig, S. Rettig, M. Lowe, 2001, Inorganic chemistry.

One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co.

U. Häfeli, E. Boros, C. Orvig, 2011, Dalton transactions.

Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease.

C. Rodríguez-Rodríguez, C. Orvig, B. Patrick, 2013, Molecular bioSystems.

Chemical Promiscuity of Non-Macrocyclic Multidentate Chelating Ligands for Radiometal Ions: H4neunpa-NH2 vs H4noneunpa.

P. Schaffer, C. Orvig, V. Radchenko, 2021, Inorganic chemistry.

Synthesis and Coordination Chemistry of Hexadentate Picolinic Acid Based Bispidine Ligands.

P. Comba, C. Orvig, H. Wadepohl, 2016, Inorganic chemistry.